DXCM
Price
$88.99
Change
+$2.25 (+2.59%)
Updated
Jul 25 closing price
Capitalization
53.47B
3 days until earnings call
IRMD
Price
$56.32
Change
-$0.28 (-0.49%)
Updated
Jul 25 closing price
Capitalization
557.04M
5 days until earnings call
Interact to see
Advertisement

DXCM vs IRMD

Header iconDXCM vs IRMD Comparison
Open Charts DXCM vs IRMDBanner chart's image
DexCom
Price$88.99
Change+$2.25 (+2.59%)
Volume$3.07M
Capitalization53.47B
iRadimed
Price$56.32
Change-$0.28 (-0.49%)
Volume$30.68K
Capitalization557.04M
DXCM vs IRMD Comparison Chart in %
Loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXCM vs. IRMD commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a StrongBuy and IRMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (DXCM: $88.99 vs. IRMD: $56.32)
Brand notoriety: DXCM and IRMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DXCM: 100% vs. IRMD: 57%
Market capitalization -- DXCM: $53.47B vs. IRMD: $557.04M
DXCM [@Medical Specialties] is valued at $53.47B. IRMD’s [@Medical Specialties] market capitalization is $557.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 0 FA rating(s) are green whileIRMD’s FA Score has 2 green FA rating(s).

  • DXCM’s FA Score: 0 green, 5 red.
  • IRMD’s FA Score: 2 green, 3 red.
According to our system of comparison, IRMD is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 5 TA indicator(s) are bullish while IRMD’s TA Score has 4 bullish TA indicator(s).

  • DXCM’s TA Score: 5 bullish, 4 bearish.
  • IRMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DXCM is a better buy in the short-term than IRMD.

Price Growth

DXCM (@Medical Specialties) experienced а +6.08% price change this week, while IRMD (@Medical Specialties) price change was -0.65% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 23, 2025.

IRMD is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($53.5B) has a higher market cap than IRMD($557M). DXCM has higher P/E ratio than IRMD: DXCM (106.11) vs IRMD (31.84). DXCM YTD gains are higher at: 14.427 vs. IRMD (3.034). DXCM has higher annual earnings (EBITDA): 917M vs. IRMD (20.8M). DXCM has more cash in the bank: 2.72B vs. IRMD (49.8M). IRMD has less debt than DXCM: IRMD (2.04M) vs DXCM (2.59B). DXCM has higher revenues than IRMD: DXCM (3.62B) vs IRMD (65.6M).
DXCMIRMDDXCM / IRMD
Capitalization53.5B557M9,605%
EBITDA917M20.8M4,409%
Gain YTD14.4273.034476%
P/E Ratio106.1131.84333%
Revenue3.62B65.6M5,521%
Total Cash2.72B49.8M5,470%
Total Debt2.59B2.04M126,970%
FUNDAMENTALS RATINGS
DXCM vs IRMD: Fundamental Ratings
DXCM
IRMD
OUTLOOK RATING
1..100
2688
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
17
Undervalued
PROFIT vs RISK RATING
1..100
10031
SMR RATING
1..100
4140
PRICE GROWTH RATING
1..100
5159
P/E GROWTH RATING
1..100
6045
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (17) in the Medical Specialties industry is significantly better than the same rating for DXCM (84). This means that IRMD’s stock grew significantly faster than DXCM’s over the last 12 months.

IRMD's Profit vs Risk Rating (31) in the Medical Specialties industry is significantly better than the same rating for DXCM (100). This means that IRMD’s stock grew significantly faster than DXCM’s over the last 12 months.

IRMD's SMR Rating (40) in the Medical Specialties industry is in the same range as DXCM (41). This means that IRMD’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's Price Growth Rating (51) in the Medical Specialties industry is in the same range as IRMD (59). This means that DXCM’s stock grew similarly to IRMD’s over the last 12 months.

IRMD's P/E Growth Rating (45) in the Medical Specialties industry is in the same range as DXCM (60). This means that IRMD’s stock grew similarly to DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMIRMD
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 9 days ago
72%
Bearish Trend 2 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FTDS54.690.24
+0.45%
First Trust Dividend Strength ETF
SPYI51.080.12
+0.24%
NEOS S&P 500(R) High Income ETF
EPOL33.350.06
+0.18%
iShares MSCI Poland ETF
ZAUG25.99N/A
+0.02%
Innovator Equity Defined Prt ETF -1YrAug
GCC20.30-0.18
-0.87%
WisdomTree Enhanced Commodity Stgy Fd

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+2.59%
CERS - DXCM
42%
Loosely correlated
+2.21%
RMD - DXCM
34%
Loosely correlated
+0.61%
IRMD - DXCM
34%
Loosely correlated
-0.49%
PEN - DXCM
33%
Loosely correlated
+1.27%
ACRS - DXCM
33%
Loosely correlated
+1.19%
More

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
-0.49%
HBIO - IRMD
51%
Loosely correlated
-0.93%
ITGR - IRMD
46%
Loosely correlated
+1.32%
VREX - IRMD
45%
Loosely correlated
+3.97%
TWST - IRMD
44%
Loosely correlated
+2.59%
ICUI - IRMD
44%
Loosely correlated
+0.55%
More